3.1. Analysis.

Comparison 3 Rivastigmine 20 cm2 patch (17.4 mg/day) versus placebo, Outcome 1 ADAS‐Cog (change from baseline at 24 weeks) ITT.

Comparison 3 Rivastigmine 20 cm2 patch (17.4 mg/day) versus placebo, Outcome 1 ADAS‐Cog (change from baseline at 24 weeks) ITT.